Techno Medica : Non-consolidated Financial Results for the Nine Months Ended December 31,2021 (Under Japanese GAAP)

Note: This document has been translated from the Japanese original for reference purposes only. In the event of any discrepancy between this translated document and the Japanese original, the original shall prevail.

February 2, 2021

Non-consolidated Financial Results

for the Nine Months Ended December 31,2021

(Under Japanese GAAP)

Company name:	Techno Medica Co., Ltd.
Listing:	Tokyo Stock Exchange
Securities code:	6678
URL:	http://www.technomedica.co.jp
Representative:	Masatomo Saneyoshi, President and CEO
Inquiries:	Kazuto Tsugawa, Director and General Manager of Corporate Management Division
Telephone:	[phone]

Scheduled date to file quarterly securities report:	February 7, 2021
Scheduled date to commence dividend payments:	―
Preparation of supplementary material on quarterly financial results: Yes
Holding of quarterly financial results briefing:	Yes (for Securities analysts, Institutional
	investors)

(Yen amounts are rounded down to millions, unless otherwise noted.)

1. Non-consolidated financial results for the Nine months ended December 31,2021 (from April 1,2021Y to December 31,2021)

(1) Non-consolidated operating results (cumulative)		(Percentages indicate year-on-year changes.)
	Net sales		Operating profit	Ordinary profit	Profit
Nine months ended	Millions of yen		%	Millions of yen		%	Millions of yen	%	Millions of yen	%
December 31,2021	6,408		9.7	974		25.8	983	25.3	673	22.3
December 31,2020	5,841		△15.5	774		△9.6	784	△8.9	550	△18.0
	Basic earnings	Diluted earnings
	per share		per share
Nine months ended			Yen			Yen
December 31,2021			79.06			―
December 31,2020			64.86			―
(2) Non-consolidated financial position
	Total assets	Net assets		Equity-to-asset ratio
As of	Millions of yen	Millions of yen		%
December 31,2021			16,975			15,120		89.1
December 31,2020			17,554			14,960		85.2
Reference: Equity
As of December 31,2021:	¥15,120 million
As of December 31,2020:	¥14,960 million

2. Cash dividends

		Annual dividends per share
	First quarter-end	Second quarter-end		Third quarter-end		Fiscal year-end	Total
	Yen	Yen		Yen		Yen	Yen
Fiscal year ended	―	0.00		―		51.00	51.00
March 31, 2021
Fiscal year ending	―
March 31, 2022
Fiscal year ending
March 31, 2022		0.00		―		51.00	51.00
(Forecast)

Note: Revisions to the forecast of cash dividends most recently announced: None

* Notes

1. Adoption of accounting treatment specific to the preparation of quarterly non-consolidated financial statements: None
2. Changes in accounting policies, changes in accounting estimates, and restatement
3. 1. Changes in accounting policies due to revisions to accounting standards and other regulations: Yes
   2. Changes in accounting policies due to other reasons: None
   3. Changes in accounting estimates: None
   4. Restatement: None
4. Number of issued shares (common shares)
5. 1. Total number of issued shares at the end of the period (including treasury shares)

As of December 31,2021	8,760,000 shares
As of December 31,2020	8,760,000 shares

(ii) Number of treasury shares at the end of the period

As of December 31,2021	291,001 shares
As of December 31,2020	240,451 shares

1. Average number of shares outstanding during the period (cumulative from the beginning of the fiscal year)

Nine months ended December 31,2021	8,514,379 shares
Nine months ended December 31,2020	8,484,887 shares

• Quarterly financial results reports are exempt from quarterly review conducted by certified public accountants or an audit corporation.
• Proper use of earnings forecasts, and other special matters
  Earnings forecasts contained in these disclosure materials are based on available information to the company and assumptions believed to be reasonable by management. This is not a promise or guarantee by the company that it will achieve these goals. Actual results may differ substantially due to several factors such as economic situation, market trend, exchange rates and other factors.

		(Thousands of yen)
	As of March 31, 2021	As of December 31, 2021
Assets
Current assets
Cash and deposits	10,138,620	11,112,578
Notes receivable - trade	87,125	25,142
Electronically recorded monetary claims -	426,259	516,575
operating
Accounts receivable - trade	3,092,542	1,905,595
Merchandise and finished goods	1,430,258	1,008,910
Work in process	98,635	129,951
Raw materials and supplies	117,134	128,876
Prepaid expenses	44,791	44,341
Other	35,197	118,351
Total current assets	15,470,566	14,990,324
Non-current assets
Property, plant and equipment
Buildings	1,184,296	1,192,926
Accumulated depreciation	△636,104	△665,145
Buildings, net	548,191	527,780
Structures	2,577	2,577
Accumulated depreciation	△2,361	△2,380
Structures, net	215	197
Machinery and equipment	350,019	350,019
Accumulated depreciation	△202,669	△222,109
Machinery and equipment, net	147,349	127,909
Tools, furniture and fixtures	272,020	288,037
Accumulated depreciation	△190,651	△223,364
Tools, furniture and fixtures, net	81,369	64,673
Land	787,326	787,326
Total property, plant and equipment	1,564,453	1,507,887
Intangible assets
Telephone subscription right	1,177	1,177
Patent right	1,331	1,157
Software	21,346	28,190
Total intangible assets	23,854	30,525
Investments and other assets
Investments in capital	7,510	7,510
Long-term prepaid expenses	74,449	55,172
Deferred tax assets	324,827	295,934
Other	88,780	88,607
Total investments and other assets	495,567	447,224
Total non-current assets	2,083,875	1,985,637
Total assets	17,554,441	16,975,961

		(Thousands of yen)
	As of March 31, 2021	As of December 31, 2021
Liabilities
Current liabilities
Accounts payable - trade	1,134,825	771,858
Accounts payable - other	176,262	101,626
Accrued expenses	79,437	91,293
Income taxes payable	390,992	23,587
Accrued consumption taxes	69,219	86,938
Advances received	215,189	313,243
Deposits received	10,267	32,608
Unearned revenue	134,346	129,052
Provision for bonuses	154,353	81,000
Provision for bonuses for directors (and other	18,000	-
officers)
Other	1,400	1,741
Total current liabilities	2,384,293	1,632,950
Non-current liabilities
Provision for retirement benefits	174,293	186,432
Provision for product warranties	104	69
Other	35,598	35,598
Total non-current liabilities	209,996	222,100
Total liabilities	2,594,290	1,855,051
Net assets
Shareholders' equity
Share capital	1,069,800	1,069,800
Capital surplus	967,926	967,926
Retained earnings	13,416,144	13,652,719
Treasury shares	△493,719	△569,534
Total shareholders' equity	14,960,151	15,120,910
Total net assets	14,960,151	15,120,910
Total liabilities and net assets	17,554,441	16,975,961